Religare Capital Markets

Jul 31, 2015 at 19:53 | Source: PTI
Of the Rs 1.80 lakh crore capital requirement estimated by the Finance Ministry, the government is willing to provide only Rs 70,000 crore - Rs 25,000 crore each in current and next fiscal and Rs 10,000 crore each in 2017-18 and 2018-19.
Jul 31, 2015 at 18:46 | Source: Moneycontrol.com
With markets in the midst of the first-quarter earnings season, analyst Prakash Diwan of Altamount Capital, Dipan Mehta and Rahul Mohindar of viratechindia.com picked out stocks and sectors they believe investors should bet on.
Jul 31, 2015 at 11:59 | Source: CNBC-TV18
Watch the interview of Krish Subramanyam of Altamount Capital with Latha Venkatesh & Ekta Batra on CNBC-TV18, in which he shared his reading and outlook on market and specific stocks.
Jul 30, 2015 at 18:34 | Source: PTI
Readying to list its shares after a bumper 32-times over-subscribed IPO, biotechnology major Biocon's research arm Syngene today said the investors have reposed faith in its future growth prospects.
Jul 30, 2015 at 10:32 | Source: CNBC-TV18
Manoj Murlidharan of Religare Securities spoke with Latha Venkatesh & Sonia Shenoy of CNBC-TV18. He shared his reading and outlook on the Futures and Options (F&O) side of the market and also gave recommendations on various stocks.
Jul 30, 2015 at 09:23 | Source: Reuters
PartnerRe has reached out to Exor in recent days to schedule discussions, the people said this week. Exor, however, is waiting for PartnerRe's board to formulate and propose the terms of a potential agreement, one of the people added.
Jul 30, 2015 at 07:56 | Source: CNBC-TV18
Paul Schatz President & CIO Heritage Capital strongly believes there is yet no case for the Fed to hike rates because global growth is still weak, Europe is teetering on recession and deflation, and Asia too is weak.
Jul 29, 2015 at 22:33 | Source: Reuters
Microsoft Corp's launch of its first new operating system in almost three years, designed to work across laptops, desktop and smartphones, won mostly positive reviews for its user-friendly and feature-packed interface.
Jul 29, 2015 at 13:43 | Source: CNBC-TV18
In an interview with CNBC-TV18, Manish Singh of Crossbridge Capital said that US Federal Reserve is likely to hike rate in September this year than in its July meeting.
Jul 29, 2015 at 13:05 | Source: Moneycontrol.com
Multicap funds are market capitalization agnostic and invest across the breadth of the equity market.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

300001 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th 2014

cleverman

Platinum Member

92 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th 2014

BSE/NSE Announcer

Platinum Member

8707 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th 2014

Web Messenger

Platinum Member

300001 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

300001 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

300001 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

300001 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

News across the web »
May 02, 2015 at 10:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.